Detroit R&D

Detroit R&D is a private, revenue-generating biotech tools and services company. It operates primarily as a supplier of specialized research reagents and diagnostic kits, with a core scientific focus on the role of soluble epoxide hydrolase (sEH) in hypertension and other diseases involving oxidative stress and drug metabolism. Its business model leverages its expertise in enzymology and biomarker detection to serve academic, pharmaceutical, and clinical researchers, rather than developing its own therapeutic drugs. The company has gained visibility through features like the Discovery Channel's 'Innovations' program.

Specialized immunoassay (ELISA) development, antibody production, and molecular biology kits for mitochondrial DNA damage and copy number analysis. Focus on biomarkers for drug metabolism enzymes (P450, sEH) and disease pathways.

Competes with specialized reagent vendors like Cayman Chemical (eicosanoids) and smaller ELISA developers, as well as broad-line giants like Thermo Fisher and Abcam. Its differentiation lies in deep expertise in specific enzymatic pathways (e.g., soluble epoxide hydrolase) and a focused product catalog not fully addressed by larger players.